Clinical Utility of HeartLogic, a Multiparametric Telemonitoring System, in Heart Failure.

IF 4.2 Q1 CARDIAC & CARDIOVASCULAR SYSTEMS

Cardiac Failure Review Pub Date : 2022-04-21 eCollection Date: 2022-01-01 DOI:10.15420/cfr.2021.35

Juan Carlos López-Azor, Noelia de la Torre, María Dolores García-Cosío Carmena, Pedro Caravaca Pérez, Catalina Munera, Irene MarcoClement, Rocío Cózar León, Jesús Álvarez-García, Marta Pachón, Fernando Arribas Ynsaurriaga, Rafael Salguero Bodes, Juan Francisco Delgado Jiménez, Javier de Juan Bagudá

{"title":"Clinical Utility of HeartLogic, a Multiparametric Telemonitoring System, in Heart Failure.","authors":"Juan Carlos López-Azor, Noelia de la Torre, María Dolores García-Cosío Carmena, Pedro Caravaca Pérez, Catalina Munera, Irene MarcoClement, Rocío Cózar León, Jesús Álvarez-García, Marta Pachón, Fernando Arribas Ynsaurriaga, Rafael Salguero Bodes, Juan Francisco Delgado Jiménez, Javier de Juan Bagudá","doi":"10.15420/cfr.2021.35","DOIUrl":null,"url":null,"abstract":"<p><p>Telemonitoring through multiple variables measured on cardiac devices has the potential to improve the follow-up of patients with heart failure. The HeartLogic algorithm (Boston Scientific), implemented in some implantable cardiac defibrillators and cardiac resynchronisation therapy, allows monitoring of the nocturnal heart rate, respiratory movements, thoracic impedance, physical activity and the intensity of heart tones, with the aim of predicting major clinical events. Although HeartLogic has demonstrated high sensitivity for the detection of heart failure decompensations, its effects on hospitalisation and mortality in randomised clinical trials has not yet been corroborated. This review details how the HeartLogic algorithm works, compiles available evidence from clinical studies, and discusses its application in daily clinical practice.</p>","PeriodicalId":33741,"journal":{"name":"Cardiac Failure Review","volume":"8 ","pages":"e13"},"PeriodicalIF":4.2000,"publicationDate":"2022-04-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ee/e5/cfr-08-e13.PMC9062709.pdf","citationCount":"3","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cardiac Failure Review","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15420/cfr.2021.35","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2022/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}

引用次数: 3

Abstract

Telemonitoring through multiple variables measured on cardiac devices has the potential to improve the follow-up of patients with heart failure. The HeartLogic algorithm (Boston Scientific), implemented in some implantable cardiac defibrillators and cardiac resynchronisation therapy, allows monitoring of the nocturnal heart rate, respiratory movements, thoracic impedance, physical activity and the intensity of heart tones, with the aim of predicting major clinical events. Although HeartLogic has demonstrated high sensitivity for the detection of heart failure decompensations, its effects on hospitalisation and mortality in randomised clinical trials has not yet been corroborated. This review details how the HeartLogic algorithm works, compiles available evidence from clinical studies, and discusses its application in daily clinical practice.

Abstract Image

查看原文本刊更多论文

HeartLogic是一种多参数远程监测系统，在心力衰竭中的临床应用。

通过在心脏设备上测量的多个变量进行远程监测有可能改善心力衰竭患者的随访。HeartLogic算法（Boston Scientific）在一些植入式心脏除颤器和心脏再同步治疗中实现，可以监测夜间心率、呼吸运动、胸部阻抗、身体活动和心率强度，目的是预测重大临床事件。尽管HeartLogic在检测心力衰竭失代偿方面表现出了很高的敏感性，但在随机临床试验中，其对住院和死亡率的影响尚未得到证实。这篇综述详细介绍了HeartLogic算法的工作原理，汇编了临床研究的可用证据，并讨论了它在日常临床实践中的应用。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Cardiac Failure Review

CiteScore

5.60

自引率

0.00%

发文量

审稿时长

9 weeks